Patent Assignment
Reel/Frame 069065/0576
Security Interest
Recorded: 2024-09-26
Pages: 16
Assignee
PROVIDENT BANK
111 WOOD AVENUE SOUTH, SUITE 200, ISELIN, NEW JERSEY, 08830
Covered Properties
(47)
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Abuse Resistant Opioid Drug-Ion Exchange Resin Complexes Having Hybrid Coatings
Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Novel Clonidine Formulation
Patent:
8,623,409 →
Application:
12/908,796 →
Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Method for Synthesizing Substituted Aminocyclohexanone Compounds
Crystalline (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,B]Indol]-4-Amine
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Solid forms of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3' H-spiro-[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine hydrochloride
Solid Forms of (1 R,4R)-6' -Fluoro-(N, N-Dimethyl)-4-Phenyl-4' ,9'-Dihydro-3'H-Spiro[ Cyclohexane-1,1 '-Pyrano-[3,4,B]Indol]-4-Amine and Sulfuric Acid
Process for the Preparation of (1R,4R)-6'-Fluoro-(N,N-Dimethyl- and N-Methyl)-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano-[3,4,B]Indol]-4-Amine
Crystalline (1r, 4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,B]Indol]-4-Amine and a Nsar
Pharmaceutical Composition Comprising (1r,4r)-6'-flouro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4'9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,B]Indol]-4-Amine and a Gabapentinoid
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Calcitonin Products and Therapies for Treating Inflammatory or Degenerative Diseases
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Benzonatate Modified Release Solid Tablets and Capsules
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Pharmaceutical Dosage Forms Comprising 6'-Fluoro-(N-Methyl- or N,N-Dimethyl-)-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,b]Indol]-4-Amine
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Benzonatate Modified Release Solid Tablets and Capsules
Methylphenidate Extended Release Chewable Tablet
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
Benzonatate Modified Release Solid Tablets and Capsules
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes
Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes
Methylphenidate Extended Release Chewable Tablet
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 2, 2007
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA
Reel/Frame 019103/0030 →
Assignment of Assignor's Interest
Jul 1, 2008
From: MEHTA, KETAN; TU, YU-HSING; CHAUDHURI, ALIVIA; PERUMAL, ASHOK
To: TRIS PHARMA
Reel/Frame 021177/0143 →
Assignment of Assignor's Interest
Mar 20, 2009
From: MEHTA, KETAN; TU, YU-HSING; SHAH, MAHENDRA
To: TRIS PHARMA, INCORPORATED
Reel/Frame 022425/0345 →
Assignment of Assignor's Interest
Dec 10, 2010
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC.
Reel/Frame 025470/0116 →
Assignment of Assignor's Interest
Jan 30, 2012
From: PRUEHS, STEFAN; GRIEBEL, CARSTEN; MUELLER, MARITA
To: GRUENENTHAL GMBH
Reel/Frame 027618/0001 →
Assignment of Assignor's Interest
Apr 17, 2012
From: MEHTA, KETAN; TU, YU-HSING; PERUMAL, ASHOK
To: TRIS PHARMA, INC.
Reel/Frame 028056/0138 →
Assignment of Assignor's Interest
May 4, 2012
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA INC
Reel/Frame 028158/0060 →
Assignment of Assignor's Interest
Aug 2, 2012
From: GRUSS, MICHAEL; KLUGE, STEFAN; PRUEHS, STEFAN
To: GRUENENTHAL GMBH
Reel/Frame 028711/0237 →
Assignment of Assignor's Interest
Jan 10, 2013
From: TU, YU-HSING; PERUMAL, ASHOK; MEHTA, KETAN
To: TRIS PHARMA, INC
Reel/Frame 029605/0799 →
Assignment of Assignor's Interest
Feb 8, 2013
From: KLUGE, STEFAN; GRUSS, MICHAEL; SIEBER, ANDREAS
To: GRUENENTHAL GMBH
Reel/Frame 029780/0577 →
Assignment of Assignor's Interest
Feb 8, 2013
From: GRUSS, MICHAEL; KLUGE, STEFAN; PRUEHS, STEFAN
To: GRUENENTHAL GMBH
Reel/Frame 029780/0796 →
Assignment of Assignor's Interest
Feb 8, 2013
From: PRUEHS, STEFAN; HELL, WOLFGANG; GRIEBEL, CARSTEN
To: GRUENENTHAL GMBH
Reel/Frame 029780/0820 →
Assignment of Assignor's Interest
Apr 17, 2013
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC
Reel/Frame 030230/0123 →
Assignment of Assignor's Interest
Jul 23, 2013
From: MEHTA, KETAN; TU, YU-HSING; SHAH, MAHENDRA
To: TRIS PHARMA, INC
Reel/Frame 030852/0965 →
Assignment of Assignor's Interest
Aug 16, 2013
From: KLUGE, STEFAN; PRUEHS, STEFAN; GRUSS, MICHAEL
To: GRUENENTHAL GMBH
Reel/Frame 031029/0376 →
Patent Security Agreement
Sep 5, 2017
From: TRIS PHARMA, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 043761/0389 →
Grant of Security Interest in Patent Rights
Sep 24, 2018
From: TRIS PHARMA, INC.
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS THE AGENT
Reel/Frame 047140/0290 →
Notice of Release of Security Interest in Patents
Sep 25, 2018
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: TRIS PHARMA, INC.
Reel/Frame 047150/0169 →
Assignment of Assignor's Interest
Aug 18, 2021
From: GRÜNENTHAL GMBH
To: PARK THERAPEUTICS, INC.
Reel/Frame 057212/0157 →
Release of Security Interest
Sep 26, 2024
From: DEERFIELD MANAGEMENT COMPANY, L.P.
To: TRIS PHARMA, INC.; NEXTWAVE PHARMACEUTICALS INCORPORATED
Reel/Frame 069054/0362 →
Change of Name
May 21, 2025
From: PARK THERAPEUTICS, INC.
To: ADNEURIS THERAPEUTICS, INC.
Reel/Frame 071349/0825 →